Tomoda Toshifumi, Hikida Takatoshi, Sakurai Takeshi
Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada.
Laboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Osaka, Japan.
Neurotherapeutics. 2017 Jul;14(3):623-629. doi: 10.1007/s13311-017-0556-5.
Disrupted-in-schizophrenia 1 (DISC1) was initially identified as a gene disrupted by a translocation mutation co-segregating with a variety of psychotic and mood disorders in a Scottish pedigree. In agreement with this original finding, mouse models that perturb Disc1 display deficits of behaviors in specific dimensions, such as cognition and emotion, but not a motor dimension. Although DISC1 is not a risk gene for sporadic cases of specific psychiatric disorders defined by categorical diagnostic criteria (e.g., schizophrenia and major depressive disorder), DISC1 is now regarded as an important molecular lead to decipher molecular pathology for specific dimensions relevant to major mental illnesses. Emerging evidence points to the role of DISC1 in the regulation of intracellular trafficking of a wide range of neuronal cargoes. We will review recent progress in this aspect of DISC1 biology and discuss how we could utilize this body of knowledge to better understand the pathophysiology of mental illnesses.
精神分裂症断裂基因1(DISC1)最初被鉴定为在一个苏格兰家系中因易位突变而断裂的基因,该突变与多种精神和情绪障碍共分离。与这一最初发现一致,扰乱Disc1的小鼠模型在特定维度(如认知和情感)上表现出行为缺陷,但在运动维度上没有。尽管DISC1不是由分类诊断标准定义的特定精神疾病(如精神分裂症和重度抑郁症)散发病例的风险基因,但DISC1现在被视为解读与主要精神疾病相关特定维度分子病理学的重要分子线索。新出现的证据表明DISC1在多种神经元货物的细胞内运输调节中发挥作用。我们将回顾DISC1生物学这方面的最新进展,并讨论如何利用这些知识更好地理解精神疾病的病理生理学。